(Q46636521)

23 December 2017

title

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons (English)

1 reference

23 December 2017

0 references

3

1 reference

23 December 2017

author name string

L K Nilsson

series ordinal

1

1 reference

23 December 2017

K R Linderholm

series ordinal

2

1 reference

23 December 2017

publication date

5 August 2005

1 reference

23 December 2017

Journal of Neural Transmission

published in

1 reference

23 December 2017

volume

113

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

557-571

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00702-005-0343-z

exact match

0 references

cites work

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Motoric sensitization and levodopa accumulation after chronic levodopa treatment in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0343-Z

Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors.

21 January 2018

1 reference

12 December 2020

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

12 December 2020

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

1 reference

12 December 2020

Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.

1 reference

12 December 2020

NMDA receptor subunits: diversity, development and disease

1 reference

12 December 2020

Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo

1 reference

12 December 2020

Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation.

1 reference

12 December 2020

Increased cortical kynurenate content in schizophrenia

1 reference

12 December 2020

Effect of Phencyclidine in Chronic Schizophrenics

1 reference

12 December 2020

Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus

1 reference

12 December 2020

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

12 December 2020

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

12 December 2020

Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

1 reference

12 December 2020

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

12 December 2020

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

12 December 2020

MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists

1 reference

12 December 2020

Kynurenic acid and schizophrenia

1 reference

12 December 2020

Modulation of N-methyl-D-aspartate receptor function by glycine transport

1 reference

12 December 2020

Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms

1 reference

12 December 2020

Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine

1 reference

12 December 2020

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

12 December 2020

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.

1 reference

12 December 2020

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

12 December 2020

Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors

1 reference

12 December 2020

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

12 December 2020

The control of firing pattern in nigral dopamine neurons: burst firing

1 reference

12 December 2020

Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands

1 reference

12 December 2020

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

1 reference

12 December 2020

Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid.

1 reference

12 December 2020

Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.

1 reference

12 December 2020

3-Hydroxyanthranilic acid oxygenase-containing astrocytic processes surround glutamate-containing axon terminals in the rat striatum

1 reference

12 December 2020

Nitric oxide is involved in nicotine-induced burst firing of rat ventral tegmental area dopamine neurons

1 reference

12 December 2020

GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo

1 reference

12 December 2020

Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes

1 reference

12 December 2020

Unconventional ligands and modulators of nicotinic receptors

1 reference

12 December 2020

New roles for astrocytes: Regulation of synaptic transmission

1 reference

12 December 2020

Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses

1 reference

12 December 2020

Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice.

1 reference

12 December 2020

Phencyclidine and the midbrain dopamine system: electrophysiology and behavior

1 reference

12 December 2020

Neuropharmacology of quinolinic and kynurenic acids

1 reference

12 December 2020

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

THE VARIABILITY OF CENTRAL NEURAL ACTIVITY IN A SENSORY SYSTEM, AND ITS IMPLICATIONS FOR THE CENTRAL REFLECTION OF SENSORY EVENTS

1 reference

12 December 2020

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

12 December 2020

Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex.

1 reference

12 December 2020

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

12 December 2020

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

1 reference

12 December 2020

Chronic corticosterone treatment alters sensory gating in C3H mice

1 reference

12 December 2020

The control of firing pattern in nigral dopamine neurons: single spike firing

1 reference

12 December 2020

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

1 reference

12 December 2020

Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats

1 reference

12 December 2020

NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity.

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

12 December 2020

Kynurenic acid inhibits the activation of kainic and N-methyl-D-aspartic acid-sensitive ionotropic receptors by a different mechanism

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.

1 reference

12 December 2020

Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid

1 reference

12 December 2020

Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis

1 reference

12 December 2020

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

1 reference

12 December 2020

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

12 December 2020

Kynurenate production by cultured human astrocytes

1 reference

12 December 2020

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes

1 reference

12 December 2020

Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area

1 reference

12 December 2020

Identification and quantification of kynurenic acid in human brain tissue.

1 reference

12 December 2020

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.

1 reference

12 December 2020

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

1 reference

12 December 2020

Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease

1 reference

12 December 2020

Presence of Kynurenic Acid in the Mammalian Brain

1 reference

12 December 2020

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

1 reference

12 December 2020

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization

1 reference

12 December 2020

Endogenous kynurenic acid disrupts prepulse inhibition

1 reference

12 December 2020

Kynurenic acid is present in the rat brain and its content increases during development and aging processes

1 reference

12 December 2020

Quinolinic acid and other kynurenines in the central nervous system

1 reference

12 December 2020

Localization of synapses in rat cortical cultures

1 reference

12 December 2020

Glutamate as a therapeutic target in psychiatric disorders

1 reference

12 December 2020

Tryptophan metabolites and brain disorders

1 reference

12 December 2020

Mind glue: implications of glial cell biology for psychiatry

1 reference

12 December 2020

Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.

1 reference

12 December 2020

Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine

1 reference

12 December 2020

10.1007/S00702-005-0343-Z

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017